Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Herrlich

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Progress in Clinical and Biological Research|January 1, 1982
Signals governing mouse mammary tumor virus expression in vivo and in cultured cells upon proviral DNA transferB Groner, H Ponta, W Günzburg, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 1, 1997
UV-induced signal transductionK Bender, C Blattner, A Knebel, et al.
Progress in Clinical and Biological Research|January 1, 1982
DNA mediated transfer and fate of a proviral gene of mouse mammary tumor virus in cultured cellsN E Hynes, U Rahmsdorf, N Kennedy, et al.
The EMBO Journal|August 1, 1997
I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptorS Heck, K Bender, M Kullmann, et al.
Experimental Cell Research|November 1, 1981
Differentiated cells from BALB/c mice differ in their radiosensitivityH J Rahmsdorf, H Ponta, M Bächle, et al.
Cancer Research|October 1, 1991
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell linesM Hofmann, W Rudy, M Zöller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblastsU Mallick, H J Rahmsdorf, N Yamamoto, et al.
Gynecologic Oncology|August 1, 1997
Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes--a model for immunogene therapy of cervical cancerP Dall, A Hekele, M W Beckmann, et al.
International Journal of Cancer|October 9, 1996
Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44v6-specific scFv:zeta-chimeraA Hekele, P Dall, D Moritz, et al.
Cell Adhesion and Communication|November 21, 1998
How tumor cells make use of CD44P Herrlich, J Sleeman, D Wainwright, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Progress in Clinical and Biological Research|January 1, 1982
Signals governing mouse mammary tumor virus expression in vivo and in cultured cells upon proviral DNA transferB Groner, H Ponta, W Günzburg, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 1, 1997
UV-induced signal transductionK Bender, C Blattner, A Knebel, et al.
Progress in Clinical and Biological Research|January 1, 1982
DNA mediated transfer and fate of a proviral gene of mouse mammary tumor virus in cultured cellsN E Hynes, U Rahmsdorf, N Kennedy, et al.
The EMBO Journal|August 1, 1997
I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptorS Heck, K Bender, M Kullmann, et al.
Experimental Cell Research|November 1, 1981
Differentiated cells from BALB/c mice differ in their radiosensitivityH J Rahmsdorf, H Ponta, M Bächle, et al.
Cancer Research|October 1, 1991
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell linesM Hofmann, W Rudy, M Zöller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblastsU Mallick, H J Rahmsdorf, N Yamamoto, et al.
Gynecologic Oncology|August 1, 1997
Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes--a model for immunogene therapy of cervical cancerP Dall, A Hekele, M W Beckmann, et al.
International Journal of Cancer|October 9, 1996
Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44v6-specific scFv:zeta-chimeraA Hekele, P Dall, D Moritz, et al.
Cell Adhesion and Communication|November 21, 1998
How tumor cells make use of CD44P Herrlich, J Sleeman, D Wainwright, et al.
Pageof 23